Introduction
Surgical treatment of patients with a functionally single ventricle and associated visceral heterotaxy is challenging. Hospital mortality after the initial palliation is high (25%-60%) and may reach 95% if the lesion is associated with obstructed total anomalous pulmonary venous return w1, 2x. According to 'classic' principles of selection for Fontan operation w3x, patients with visceral heterotaxy are not 'ideal' candidates for this procedure, because of multiple risk factors related to the presence of concomitant anomalies. This group of patients frequently has anomalies of the systemic and pulmonary veins, the dominant right ventricle with compromised ejection fraction, and the regurgitant common atrioventricular valve as well as a variable anatomy of the sinus node predisposing to arrhythmias. In the 1980s, hospital mortality after modified Fontan operation (MFO) performed in patients with heterotaxy reached 43%-80% w4, 5x. However, the progress achieved since that time in surgical technique and postoperative care resulted in a significant decrease in mortality w6, 7x. A staged surgical approach, when bidirectional cavopulmonary anastomosis (BCPA) precedes MFO, became a thoroughly used strategy w6, 8x. However, not all investigators share the opinion that visceral heterotaxy is no longer a risk factor for hemodynamic correction of complex congenital heart defects w8x. The goal of this study is to analyze our experience with BCPA and MFO in patients with a functionally single ventricle and concomitant heterotaxy as well as to reveal corresponding risk factors.
Materials and methods

Patient population
During 1983-2010, a total of 681 consecutive patients with a functionally single ventricle underwent BCPA or MFO. Thirty-nine of them (5.7%) had a visceral heterotaxy.
Thirty-one patients with heterotaxy were subjected to BCPA only, seven to BCPA followed by MFO, and one to MFO only. The age of patients at the time of the aforementioned procedures ranged from one to 29 (median, eight) years. Prior to these interventions, two patients underwent Blalock-Taussig shunt, five a Gore-Tex shunt and two a Vishnevsky-Donetsky shunt (subclavian artery-to-pulmonary Downloaded from https://academic.oup.com/icvts/article-abstract/12/4/563/723926 by guest on 22 December 2018 shunt with a lyophilized graft). The interval between BCPA and MFO ranged from one to 15 (mean, eight) years. Thirtyseven patients were followed-up after BCPA or MFO.
Study protocol
The study protocol was approved by the Ethical Committee of Bakoulev Center for Cardiovascular Surgery. Medical records of 39 patients with heterotaxy were reviewed for demographics and preoperative and postoperative parameters. Medical records of patients without heterotaxy subjected to BCPA or MFO were reviewed for outcomes only.
Anatomy and preoperative hemodynamics
Cardiac anatomy and concomitant anomalies are presented in Tables 1 and 2. Patients with the left isomerism had polysplenia, whereas patients with the right isomerism had asplenia. Thirty-one patients (74%) had a regurgitation of different severity at the atrioventricular valves.
Preoperative parameters are presented in Table 3 . Thirtyeight patients had preoperative sinus rhythm and one had a nodal rhythm. Six patients prior to BCPA and one patient prior to MFO had mean pulmonary arterial pressure exceeding 15 mmHg. Pulmonary vascular resistance (PVR) exceeded 4 units=m in two patients prior to BCPA only. Four 2 patients prior to BCPA and two patients before MFO had mild-to-moderate hypoplasiaystenosis of pulmonary arteries, and their pulmonary arterial Nakata index was below 200 mmym . The average number of exceeded 'operability' 2 using Choussat et al. criteria was significantly higher in patients subjected to BCPA than in patients that underwent MFO (2.2"0.7 vs. 1.6"0.6, Ps0.043).
Surgical techniques
One-sided and bilateral BCPA was performed in 18 and 20 patients, respectively. Fontan modifications included extracardiac conduit (ns7) and fenestrated lateral tunnel (ns1). Additional procedures performed simultaneously with BCPA or MFO are presented in Table 4 .
Statistical analysis
The data are presented as mean"S.D. andyor median and range, as appropriate or absolute numbers and percentages. The Student's t-test or analysis of variance (ANOVA) was used to compare continuous variables, as appropriate. Chi-square (x ) analysis was used to test for differences in I. A. Yurlov et al. / Interactive CardioVascular and Thoracic Surgery 12 (2011) 
Results
Course of the hospital period
Hospital mortality after BCPA reached 7.9% (3y38). Two patients experienced heart failure and hypoxemia after the completion of BCPA. Creation of aorta-to-pulmonary anastomosis did not lead to the increase in arterial blood oxygen saturation (SaO ) and improvement of hemodynamics. The 2 third patient died on the 10th day after BCPA from heart failure and renal failure that required hemodialysis. This patient also suffered from supraventricular tachycardia. In all three cases, preoperative profile was remarkable for moderate insufficiency of the common atrioventricular valve and the presence of bilateral venae cava. One patient also had a hypoplasia of the left pulmonary artery. The hospital mortality after BCPA in patients with and without heterotaxy did not differ significantly w7.9% (3y8) vs. 6.9% (18y259), Ps0.898x.
One patient died on the 23rd day after the Fontan operation (extracardiac conduit and replacement of the common atrioventricular valve) from heart and renal failure. There was no dysfunction of the valve prosthesis. Except for the severe insufficiency of the atrioventricular valve, the patient's preoperative profile was remarkable for a moderate hypoplasia of the right pulmonary artery. The hospital mortality after MFO in patients with and without heterotaxy did not significantly differ w12.5% (1y8) vs. 11.7% (44y376), Ps0.627x.
Non-lethal hospital complications after BCPA and MFO are presented in Table 5 . Duration of hospital stay was longer in patients after MFO (41.0"18.0 days vs. 15.5"7.3 days, Ps0.048). Patients who died or developed postoperative complications after BCPA or MFO had a significantly higher number of exceeded 'operability' criteria than those with uneventful hospital period (2.2"0.5 vs. 1.6"0.4, Ps0.04).
SaO at discharge after MFO and BCPA was 90.3"2.6% and 2 85.6"5.8%, respectively (Ps0.034). SaO after both surgi- 
Course of the follow-up period
Follow-up of patients after BCPA and MFO is presented in Table 6 . The duration of follow-up after BCPA was significantly longer than after MFO (Ps0.000).
One patient died 10 years after BCPA (Table 7) . Lethal outcomes after MFO occurred at three months, six months, and three years after surgery, respectively. Actuarial fiveand 10-year survival after BCPA and MFO was 83% and 76%, respectively. Late mortality after BCPA and MFO in patients with and without heterotaxy did not significantly differ (8.7% and 9.5%, respectively; Ps0.926).
Patients after both surgical interventions that underwent follow-up examination at our institution significantly improved their functional class and SaO compared to 2 preoperative values ( Table 6 ). SaO after MFO was signifi-2 cantly higher than after BCPA (Ps0.000). Transluminal balloon dilatationystenting of pulmonary arteries was successful after BCPA and led to only temporary partial relief of symptoms in a patient after MFO. Residual regurgitation at atrioventricular valves ( Table 6 ) worsened patients' condition.
Risk factors for BCPA and MFO
The only independent risk factor for a hospital or late lethal outcome in patient with heterotaxy was moderateto-severe preoperative insufficiency of atrioventricular valves (Ps0.012) ( Table 8) .
Discussion
In the majority of published series, the number of MFO performed in patients with visceral heterotaxy ranges from 20 to 60 w4, 8-12x. The largest series include 135-142 cases w6, 7x. Most commonly, hospital mortality ranges from 3% to 20% w6, 8-11x. Over the years, the hospital mortality dramatically dropped from 40%-80% in the 1980s w4, 5x to 4%-5% in surgical series published in 2006-2010 w8, 10x. There is a dependency of mortality rate on the year of operation w6, 7x. In our small series of MFO collected during year period, the hospital mortality reaches 12.5%. Despite the reduction in mortality, it remains disputable whether a visceral heterotaxy is a risk factor for lethal outcomes after MFO w8, 9, 13x. It has become clear that not heterotaxy per se but the complexity of cardiac malformations asso-Downloaded from https://academic.oup.com/icvts/article-abstract/12/4/563/723926 by guest on 22 December 2018 I. A. Yurlov et al. / Interactive CardioVascular and Thoracic Surgery 12 (2011) ciated with this syndrome may negatively influence results of hemodynamic correction. Variable anatomy of the sinus node is typical for heterotaxy syndrome. Cardiac rhythm disturbances were found in 23%-36% patients with visceral heterotaxy prior to BCPA or MFO w6, 11, 14x . Surprisingly, we have revealed preoperative nodal bradycardia in one (3%) patient only. This is probably because of the absence of a routine Holter monitoring.
In our series, 74% patients with heterotaxy had common atrioventricular valve, which is consistent with the observations of other authors (73%-83%) w6, 14, 15x. The common valve demonstrated moderate-to-severe regurgitation in 79% patients, and had a multileaflet anatomy (four to six leaflets) in 34% of cases.
Thus, patients with visceral heterotaxy may accumulate potential risk factors for MFO. However, there are only a few works that have statistical power to determine if patients with heterotaxy have worse outcomes after this intervention than those without heterotaxy. Culbertson et al. did not report significant differences in mortality after MFO between patients with and without heterotaxy (20% vs. 8.5%) w9x. Kim et al. showed that hospital mortality in the heterotaxy group was significantly higher (4.8% vs. 2.4%) w8x. At the same time, the authors failed to reveal differences in postoperative hemodynamics, duration of mechanical ventilation, chest tubes, intensive care unit and hospital stay between patients with and without heterotaxy. Koudieh et al. demonstrated that both hospital and late mortality after BCPA was significantly higher in patients with heterotaxy (9% vs. 0.8% and 6% vs. 1.6%) w14x. Moreover, the duration of mechanical ventilation, inotropic support, intensive care unit and hospital stay was also significantly longer in patients with heterotaxy. In our series, hospital and late mortality after BCPA and MFO did not significantly differ in patients with and without heterotaxy.
There is more data showing which factors influence surgical results in patients with visceral heterotaxy. These factors are regurgitation at atrioventricular valves or valve replacement w7, 9, 14x, elevated pulmonary arterial pressure w12x or PVR w9x, elevated end-diastolic pressure of the systemic ventricle w10x, and prolonged cardiopulmonary bypass w10x. Our analysis has shown that only preoperative moderate-to-severe regurgitation at atrioventricular valves is a risk factor for lethal outcomes after BCPA and MFO in patients with heterotaxy.
Late mortality after MFO in patients with heterotaxy ranges from 3% to 10% w6, 8-11x. There is almost no comparison of functional status in patients with and without heterotaxy after surgery. Surprisingly, despite the high frequency of arrhythmias in patients with heterotaxy subjected to Fontan operation, 80%-100% of them are classified as I-II NYHA class w6, 7, 10x. Atz et al. did not find differences in exercise performance after MFO in patients with and without heterotaxy w13x. Our data indicate that residual regurgitation at atrioventricular valves in patients with heterotaxy contributes to deterioration of their condition both after BCPA and MFO. According to the literature, 40%-76% patients with heterotaxy subjected to MFO have at least mild regurgitation at the atrioventricular valves at follow-up.
Our study has several limitations. First of all, this a nonrandomized, retrospective study. BCPA and MFO in patients with visceral heterotaxy syndrome were performed throughout a 27-year period. During three decades, significant improvements in surgical technique, anesthesiological, and postoperative care were achieved. Thus, there was no standard of care applied to the patient population. Second, we have compared only the frequency of lethal outcomes after BCPA and MFO but not the frequency of complications in patients with and without heterotaxy. Besides, the number of patients that were subjected to MFO was not enough to determine risk factors for MFO and BCPA separately. Last, the period of follow-up after MFO was short.
In conclusion, our study did not reveal significant differences in mortality after BCPA and MFO in patients with a functionally single ventricle with and without concomitant visceral heterotaxy. Longer periods of follow-up are needed to conclude whether heterotaxy is a risk factor for these interventions. Preoperative insufficiency of atrioventricular valves negatively influences surgical results. That is why not only a severe but also a moderate regurgitation at atrioventricular valves should be corrected. However, the long-lasting effectiveness of valvular repair remains challenging.
